Hyperglycemic Crises in Adults With Diabetes: A Consensus Report

Overview

Journal Diabetes Care

Specialty Endocrinology

Date 2024 Jul 25

PMID 39052901

Authors

Guillermo E Umpierrez

Georgia M Davis

Nuha A ElSayed

Gian Paolo Fadini

Rodolfo J Galindo

Irl B Hirsch

David C Klonoff

Rozalina G McCoy

Shivani Misra

Robert A Gabbay

Raveendhara R Bannuru

Ketan K Dhatariya

Affiliations

Soon will be listed here.

Abstract

The American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD), Joint British Diabetes Societies for Inpatient Care (JBDS), American Association of Clinical Endocrinology (AACE), and Diabetes Technology Society (DTS) convened a panel of internists and diabetologists to update the ADA consensus statement on hyperglycemic crises in adults with diabetes, published in 2001 and last updated in 2009. The objective of this consensus report is to provide up-to-date knowledge about the epidemiology, pathophysiology, clinical presentation, and recommendations for the diagnosis, treatment, and prevention of diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS) in adults. A systematic examination of publications since 2009 informed new recommendations. The target audience is the full spectrum of diabetes health care professionals and individuals with diabetes.

Citing Articles

Gentiopicroside targeting AKT1 activates HIF-1α/VEGF axis promoting diabetic ulcer wound healing.

Wang X, Liu M, Wu Y, Sun J, Liu L, Pan Z Front Pharmacol. 2025; 16:1506499.

PMID: 40078292 PMC: 11897484. DOI: 10.3389/fphar.2025.1506499.

Diabetic ketoacidosis and hyperglycemic hyperosmolar state are associated with higher in-hospital mortality and morbidity in diabetes patients hospitalized with ST-elevation myocardial infarction, but not within 30 days of readmission.

Almutairi T, Dargham S, Jayyousi A, Suwaidi J, Abi Khalil C PLoS One. 2025; 20(2):e0318774.

PMID: 39913488 PMC: 11801527. DOI: 10.1371/journal.pone.0318774.

Continuous Glucose Monitoring in Hospitalized Adults With Diabetic Ketoacidosis: A Prospective Open-Label Pilot Study.

Bogun M, Wang C, Kurlansky P, Bedeir N, Umpierrez G J Diabetes Sci Technol. 2025; :19322968251316887.

PMID: 39907056 PMC: 11800229. DOI: 10.1177/19322968251316887.

Insulin Titration Recommendations When Using Glucagon-Like Peptide 1 Receptor Agonist Therapy in Adults With Type 1 Diabetes.

Saeed Z, Akturk H, Aleppo G, Kruger D, Levy C, Mader J Clin Diabetes. 2025; 43(1):131-138.

PMID: 39829697 PMC: 11739354. DOI: 10.2337/cd24-0067.

Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement: A consensus....

El-Boghdadly K, Dhesi J, Fabb P, Levy N, Lobo D, McKechnie A Anaesthesia. 2025; 80(4):412-424.

PMID: 39781571 PMC: 11885194. DOI: 10.1111/anae.16541.

References

Laffel L . Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. 2000; 15(6):412-26. DOI: 10.1002/(sici)1520-7560(199911/12)15:6<412::aid-dmrr72>3.0.co;2-8. View

Nyenwe E, Kitabchi A . Evidence-based management of hyperglycemic emergencies in diabetes mellitus. Diabetes Res Clin Pract. 2011; 94(3):340-51. DOI: 10.1016/j.diabres.2011.09.012. View

Wei W, Lin S, Hsu J, Wu Y, Loh C, Huang H . Association between Hyperosmolar Hyperglycemic State and Venous Thromboembolism in Diabetes Patients: A Nationwide Analysis in Taiwan. J Pers Med. 2022; 12(2). PMC: 8880712. DOI: 10.3390/jpm12020302. View

Nip A, Lodish M . Trend of Diabetes-Related Hospital Admissions During the Transition Period From Adolescence to Adulthood in the State of California. Diabetes Care. 2021; 44(12):2723-2728. DOI: 10.2337/dc21-0555. View

Umpierrez G, Latif K, Stoever J, Cuervo R, Park L, Freire A . Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med. 2004; 117(5):291-6. DOI: 10.1016/j.amjmed.2004.05.010. View

Elliott J, Jacques R, Kruger J, Campbell M, Amiel S, Mansell P . Substantial reductions in the number of diabetic ketoacidosis and severe hypoglycaemia episodes requiring emergency treatment lead to reduced costs after structured education in adults with Type 1 diabetes. Diabet Med. 2014; 31(7):847-53. PMC: 4264891. DOI: 10.1111/dme.12441. View

Jahangir A, Jahangir A, Siddiqui F, Niazi M, Yousaf F, Muhammad M . Normal Saline Versus Low Chloride Solutions in Treatment of Diabetic Ketoacidosis: A Systematic Review of Clinical Trials. Cureus. 2022; 14(1):e21324. PMC: 8848863. DOI: 10.7759/cureus.21324. View

Huang J, Yeung A, Bergenstal R, Castorino K, Cengiz E, Dhatariya K . Update on Measuring Ketones. J Diabetes Sci Technol. 2023; 18(3):714-726. PMC: 11089855. DOI: 10.1177/19322968231152236. View

Fisher L, Polonsky W, Naranjo D, Strycker L, Hessler D . A novel approach to understanding and assessing the emotional side of type 1 diabetes: The Type 1-Diabetes Distress Assessment System. Diabet Med. 2024; 41(7):e15282. DOI: 10.1111/dme.15282. View

10.

Albanese-ONeill A, Wu M, Miller K, Jacobsen L, Haller M, Schatz D . Poor Adherence to Ketone Testing in Patients With Type 1 Diabetes. Diabetes Care. 2017; 40(4):e38-e39. DOI: 10.2337/dc16-2620. View

11.

Fadini G, de Kreutzenberg S, Rigato M, Brocco S, Marchesan M, Tiengo A . Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center. Diabetes Res Clin Pract. 2011; 94(2):172-9. DOI: 10.1016/j.diabres.2011.06.018. View

12.

Wolfsdorf J, Ratner R . SGLT Inhibitors for Type 1 Diabetes: Proceed With Extreme Caution. Diabetes Care. 2019; 42(6):991-993. DOI: 10.2337/dci19-0008. View

13.

Javor K, Kotsanos J, McDonald R, Baron A, Kesterson J, Tierney W . Diabetic ketoacidosis charges relative to medical charges of adult patients with type I diabetes. Diabetes Care. 1997; 20(3):349-54. DOI: 10.2337/diacare.20.3.349. View

14.

Yuen K, McDaniel P, Riddle M . Twenty-four-hour profiles of plasma glucose, insulin, C-peptide and free fatty acid in subjects with varying degrees of glucose tolerance following short-term, medium-dose prednisone (20 mg/day) treatment: evidence for differing effects on insulin.... Clin Endocrinol (Oxf). 2011; 77(2):224-32. PMC: 3700529. DOI: 10.1111/j.1365-2265.2011.04242.x. View

15.

Andrade-Castellanos C, Colunga-Lozano L, Delgado-Figueroa N, Gonzalez-Padilla D . Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis. Cochrane Database Syst Rev. 2016; (1):CD011281. PMC: 8829395. DOI: 10.1002/14651858.CD011281.pub2. View

16.

Kitabchi A, Ayyagari V, Guerra S . The efficacy of low-dose versus conventional therapy of insulin for treatment of diabetic ketoacidosis. Ann Intern Med. 1976; 84(6):633-8. DOI: 10.7326/0003-4819-84-6-633. View

17.

Hurtado C, Lemor A, Vallejo F, Lopez K, Garcia R, Mathew J . CAUSES AND PREDICTORS FOR 30-DAY RE-ADMISSIONS IN ADULT PATIENTS WITH DIABETIC KETOACIDOSIS IN THE UNITED STATES: A NATIONWIDE ANALYSIS, 2010-2014. Endocr Pract. 2019; 25(3):242-253. DOI: 10.4158/EP-2018-0457. View

18.

Paulson W, Gadallah M . Diagnosis of mixed acid-base disorders in diabetic ketoacidosis. Am J Med Sci. 1993; 306(5):295-300. DOI: 10.1097/00000441-199311000-00004. View

19.

Khunti K, Del Prato S, Mathieu C, Kahn S, Gabbay R, Buse J . COVID-19, Hyperglycemia, and New-Onset Diabetes. Diabetes Care. 2021; 44(12):2645-2655. PMC: 8669536. DOI: 10.2337/dc21-1318. View

20.

Dhatariya K . Defining and characterising diabetic ketoacidosis in adults. Diabetes Res Clin Pract. 2019; 155:107797. DOI: 10.1016/j.diabres.2019.107797. View